Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer

Carolin C Schneider1, Claudia Götz, Andrea Hessenauer

  • 1Medizinische Biochemie und Molekularbiologie, Universität des Saarlandes, Gebäude 44, 66421 Homburg, Germany.

Summary

Protein kinase CK2 (CK2) regulates the cell cycle and has anti-apoptotic functions. Inhibiting CK2 reduces cdc25C levels and induces apoptosis, but cdc25C down-regulation is not required for this cell death.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...